Among the group who say there should be more government regulation of drug prices, seven in ten (70% or 46% of all adults) said there should be more regulation even if it means pharmaceutical companies do less research and development of new drugs. In contrast, this argument swayed almost one-quarter (23% or 15% of the total) who say there should NOT be more government regulation of prices if it impacted future development of drugs.